Feedback / Questions
CTD-402 - Nanjing Bioheng Biotech
https://www.globenewswire.com/news-release/2025/12/08/3202001/0/en/Imviva-Biotech-Presents-Clinical-Breakthroughs-for-CTD402-in-High-Mortality-T-Cell-and-Myeloid-Leukemias-at-the-67th-American-Society-of-Hematology-Annual-Meeting.html
Dec 8, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next